(Q34228158)

31 July 2017

Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade (English)

1 reference

31 July 2017

1 reference

1 reference

Richard M Martin

8

0 references

David E. Neal

object named as

David E Neal

6

0 references

Jenny L Donovan

4

object named as

Jenny Donovan

1 reference

31 July 2017

5

Freddie Hamdy

1 reference

31 July 2017

Rebecca Gilbert

1

1 reference

31 July 2017

Chris Metcalfe

2

1 reference

31 July 2017

William D Fraser

3

1 reference

31 July 2017

J Athene Lane

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

21 December 2011

1 reference

International Journal of Cancer

31 July 2017

1 reference

31 July 2017

131

1 reference

31 July 2017

5

1 reference

31 July 2017

1187-1196

1 reference

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Missing covariate data in medical research: to impute is better than to ignore

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Prevalence and correlates of vitamin D status in African American men

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Vitamin D assessment in population-based studies: a review of the issues

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Blood biomarkers of vitamin D status

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

How should variable selection be performed with multiply imputed data?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Vitamin D and African Americans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Vitamin D and the epidemiology of prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

The role of Vitamin D3 metabolism in prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Prostate-specific antigen test use reported in the 2000 National Health Interview Survey

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Using lowess to remove systematic trends over time in predictor variables prior to logistic regression with quantile categories

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378478

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries

5 July 2018

1 reference

Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk.

21 January 2018

1 reference

Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review

21 January 2018

1 reference

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.

21 January 2018

1 reference

Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men.

21 January 2018

1 reference

UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States)

21 January 2018

1 reference

The relation between adiposity throughout the life course and variation in IGFs and IGFBPs: evidence from the ProtecT (Prostate testing for cancer and Treatment) study

21 January 2018

1 reference

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

21 January 2018

1 reference

12 December 2020

Vitamin D and prostate cancer

1 reference

12 December 2020

Vitamin D and prostate cancer

1 reference

12 December 2020

Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089

1 reference

12 December 2020

Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer

1 reference

12 December 2020

Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.27327

1 reference

31 July 2017

1 reference

31 July 2017

1 reference